Cargando…

An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes

BACKGROUND: Dengue is a public health problem of global significance for which there is neither an effective antiviral therapy nor a preventive vaccine. It is a mosquito-borne viral disease, caused by dengue (DEN) viruses, which are members of the Flaviviridae family. There are four closely related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanam, Saima, Rajendra, Pilankatta, Khanna, Navin, Swaminathan, Sathyamangalam
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805746/ https://www.ncbi.nlm.nih.gov/pubmed/17302980 http://dx.doi.org/10.1186/1472-6750-7-10

Ejemplares similares

Adenovirus Delivered Short Hairpin RNA Targeting a Conserved Site in the 5′ Non-Translated Region Inhibits All Four Serotypes of Dengue Viruses
por: Korrapati, Anil Babu, et al.
Publicado: (2012)

A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
por: Raut, Rajendra, et al.
Publicado: (2015)

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
por: Arora, Upasana, et al.
Publicado: (2012)

Occurrence of concurrent infections with multiple serotypes of dengue viruses during 2013–2015 in northern Kerala, India
por: Reddy, Manchala Nageswar, et al.
Publicado: (2017)

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes
por: Sood, Ruchi, et al.
Publicado: (2015)

Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera
por: Batra, Gaurav, et al.
Publicado: (2011)

Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
por: Rajpoot, Ravi Kant, et al.
Publicado: (2018)

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
por: Tripathi, Lav, et al.
Publicado: (2015)

Prime–boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu(+ )metastatic breast cancer in mice
por: Wang, Xiaoyan, et al.
Publicado: (2005)

Comparison of equipotent doses of rocuronium and vecuronium
por: Parasa, Mrunalini, et al.
Publicado: (2015)

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris
por: Kaushik, Neha, et al.
Publicado: (2016)

Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
por: Mani, Shailendra, et al.
Publicado: (2013)

Dengue-specific subviral nanoparticles: design, creation and characterization
por: Khetarpal, Niyati, et al.
Publicado: (2013)

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
por: Poddar, Ankur, et al.
Publicado: (2016)

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
por: Ramasamy, Viswanathan, et al.
Publicado: (2018)

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
por: Shukla, Rahul, et al.
Publicado: (2020)

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
por: Shukla, Rahul, et al.
Publicado: (2018)

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients
por: Butterfield, Lisa H, et al.
Publicado: (2014)

Prevention of hypotension associated with the induction dose of propofol: A randomized controlled trial comparing equipotent doses of phenylephrine and ephedrine
por: Farhan, Muhammad, et al.
Publicado: (2015)

Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia
por: Elder, A, et al.
Publicado: (2017)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

Simultaneous detection of Human Immunodeficiency Virus 1 and Hepatitis B virus infections using a dual-label time-resolved fluorometric assay
por: Myyryläinen, Tiina, et al.
Publicado: (2010)

Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep
por: Wang, Yan, et al.
Publicado: (2023)

A novel oncolytic adenovirus based on simian adenovirus serotype 24
por: Cheng, Tao, et al.
Publicado: (2017)

Fiber-1 of serotype 4 fowl adenovirus mediates superinfection resistance against serotype 8b fowl adenovirus
por: Lu, Hao, et al.
Publicado: (2022)

Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
por: Luo, Shengxue, et al.
Publicado: (2021)

Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial
por: Jaiswal, Binaya Kumar, et al.
Publicado: (2023)

Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques
por: Keelapang, Poonsook, et al.
Publicado: (2023)

The serotype of adenoviruses detected in faeces by electron microscopy
por: Bryden, AS, et al.
Publicado: (1993)

Escherichia coli–expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen
por: Talha, Sheikh M, et al.
Publicado: (2012)

Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2
por: George, Junu A., et al.
Publicado: (2011)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2015)

A slow, efficient and safe nanoplatform of tailored ZnS QD-mycophenolic acid conjugates for in vitro drug delivery against dengue virus 2 genome replication
por: Dungdung, Ranjeet, et al.
Publicado: (2020)

Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model
por: Kosinska, Anna D., et al.
Publicado: (2013)

Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.
por: Pace, P., et al.
Publicado: (1997)

Early CD8 T-cell memory precursors and terminal effectors exhibit equipotent in vivo degranulation
por: Yuzefpolskiy, Yevgeniy, et al.
Publicado: (2015)

Mirror‐Image Packing Provides a Molecular Basis for the Nanomolar Equipotency of Enantiomers of an Experimental Herbicide
por: Bisson, Claudine, et al.
Publicado: (2016)

Mouse Spermatogenic Stem Cells Continually Interconvert between Equipotent Singly Isolated and Syncytial States
por: Hara, Kenshiro, et al.
Publicado: (2014)

Coherence of Visual-Evoked Gamma Oscillations Is Disrupted by Propofol but Preserved Under Equipotent Doses of Isoflurane
por: Aggarwal, Adeeti, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fov3p3u8jsnithrnc7r9n0vue5